As radiopharmaceuticals continue to evolve, the convergence of scientific innovation, operational practicality, and clinical expertise is opening new possibilities in oncology. The post Precision Delivered: How Radiopharmaceuticals Are Reshaping Cancer Care appeared first on MedCity News.
Direct-to-patient (DTP) models create a continuous loop of value, connecting seamless patient and provider experience with the strategic power of branding and data. The post The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience appeared first on MedCity News.
The AI Health Fund launched Treehub, a new residency program designed to back and build healthcare AI startups at the earliest stages, often before companies are even formed. It is supported by prominent figures in the Silicon Valley venture capital world, including Tim Draper and Anne Wojcicki. The post Top Silicon Valley VCs Are Backing…
Regeneron Pharmaceuticals’ Otarmeni is now approved for treating hearing loss from an ultra-rare genetic mutation found in an estimated 50 newborns per year. While Regeneron will offer this gene therapy for free, the approval came with a rare pediatric disease priority review voucher that the company can sell for hundreds of millions of dollars. The…
SCAN Health Plan CEO Sachin Jain urged brokers to abandon for-profit plans that treat them poorly, but one broker argued they often can’t because dominant players like UnitedHealth Group control so much of the healthcare system. The post SCAN CEO Urges Brokers to Drop Plans That Treat Them Poorly — One Says She Has No…
[Sponsored] In this episode, MedCity News’ Arundhati Parmar chats with a pharmacy benefits leader and a virtual pharmacy operator about ways to modernize and scale prior authorization. The post MedCity Pivot Podcast: Modernizing Prior Auth appeared first on MedCity News.
The question is no longer whether shareback matters. It is whether the healthcare ecosystem is willing to prioritize it in practice by recognizing it in policy measurement, monitoring, and enforcement, as well as investing in the technical and governance structures needed to make shareback routine, high-quality, measurable, and reportable. The post Why Quality Shareback is…
Healthcare has solved for the hard part. The science, the surgery, the diagnosis: by global standards, we’re exceptional. What we haven’t solved for is what happens when the patient goes home. The post The Healthcare Industry Has a Last Mile Problem — It Hasn’t Realized It Yet appeared first on MedCity News.
At the Medicarians Conference, Ricardo Carcas, assistant special agent in charge of the Office of Investigations, discussed cases of fraud in the ACA and how the DOJ is combatting it. The post How the DOJ Is Tackling Fraud in the ACA Marketplace appeared first on MedCity News.
Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pairs two molecules that bring different mechanisms of action to suppressing HIV. The post FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral…